Position in BSX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$624,195
-$293,523 QoQ
Shares Held
14,625
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#790
of 1,464 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BSX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026LYNX CAPITAL GROUP LTD /ADV holds $4,748,600 across 2 Medical Devices names. BSX ranks #2 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
45,453 | $4,124,405 | |
| 2 | BSX |
Boston Scientific Corp
This page
|
14,625 | $624,195 |
All Filings in BSX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $624,195 | 14,625 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $917,718 | 14,625 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $1,394,493 | 14,625 | Shares | Sole | 2026-08-12 | |
| 2025-09-30 | $1,427,838 | 14,625 | Shares | Sole | 2026-08-12 | |
| 2025-06-30 | $1,570,871 | 14,625 | Shares | Sole | 2026-08-12 | |
| 2025-03-31 | $1,475,370 | 14,625 | Shares | Sole | 2026-08-12 | |
| 2024-12-31 | $1,306,305 | 14,625 | Shares | Sole | 2026-08-10 | |
| 2024-09-30 | $1,225,575 | 14,625 | Shares | Sole | 2026-08-10 | |
| 2024-06-30 | $1,180,178 | 15,325 | Shares | Sole | 2026-08-10 | |
| 2024-03-31 | $1,049,609 | 15,325 | Shares | Sole | 2026-08-10 | |
| 2023-12-31 | $885,938 | 15,325 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||